SU530684A1 - Medication for the treatment of chronic nicotinism - Google Patents
Medication for the treatment of chronic nicotinismInfo
- Publication number
- SU530684A1 SU530684A1 SU1710668A SU1710668A SU530684A1 SU 530684 A1 SU530684 A1 SU 530684A1 SU 1710668 A SU1710668 A SU 1710668A SU 1710668 A SU1710668 A SU 1710668A SU 530684 A1 SU530684 A1 SU 530684A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- hydrochloride
- tablets
- hours
- price
- anabasine
- Prior art date
Links
- 230000001684 chronic effect Effects 0.000 title claims description 4
- 229940079593 drug Drugs 0.000 title claims 3
- 239000003814 drug Substances 0.000 title claims 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 10
- VTMZQNZVYCJLGG-PPHPATTJSA-N 3-[(2s)-piperidin-2-yl]pyridine;hydrochloride Chemical compound Cl.N1CCCC[C@H]1C1=CC=CN=C1 VTMZQNZVYCJLGG-PPHPATTJSA-N 0.000 claims description 8
- MTXSIJUGVMTTMU-JTQLQIEISA-N (S)-anabasine Chemical compound N1CCCC[C@H]1C1=CC=CN=C1 MTXSIJUGVMTTMU-JTQLQIEISA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 5
- 229930014345 anabasine Natural products 0.000 claims description 3
- 210000004185 liver Anatomy 0.000 claims description 3
- 235000019504 cigarettes Nutrition 0.000 claims 2
- 239000000779 smoke Substances 0.000 claims 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims 1
- 241000208365 Celastraceae Species 0.000 claims 1
- 206010019233 Headaches Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 206010028813 Nausea Diseases 0.000 claims 1
- 235000000336 Solanum dulcamara Nutrition 0.000 claims 1
- 230000004872 arterial blood pressure Effects 0.000 claims 1
- 230000009286 beneficial effect Effects 0.000 claims 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims 1
- 235000013539 calcium stearate Nutrition 0.000 claims 1
- 239000008116 calcium stearate Substances 0.000 claims 1
- 239000013078 crystal Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 239000011521 glass Substances 0.000 claims 1
- 231100000869 headache Toxicity 0.000 claims 1
- 230000008693 nausea Effects 0.000 claims 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims 1
- 229960002715 nicotine Drugs 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 230000005586 smoking cessation Effects 0.000 claims 1
- 230000000391 smoking effect Effects 0.000 claims 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 229910021529 ammonia Inorganic materials 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 206010038678 Respiratory depression Diseases 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Изобретение относитс к области меци- цины и может использоватьс цп печени хронического никотинизма.The invention relates to the field of methicine and can be used in chronic nicotineism cp.
Известно применение анабазина в качестве инсектицида цп сельскохоз йственных культур l .Anabasin is known to be used as an insecticide for cp of agricultural crops. L.
Цель изобретени - применение анабазина гиарохлорица в качестве стимул тора дыхани цп печени хронического :никотинизма .The purpose of the invention is the use of anabasine hyarochloric as a stimulant of respiratory depression of chronic liver: nicotinism.
Анабазин гицрохлориа представл ет собой соединение с6-пиперидин - В - ли- ридин гидрохлорид со структурной формунееAnabazin hy- drochloria is a compound c6-piperidine - B - lidirine hydrochloride with structural form
пой ,jsing j
Анабазин гидрохлорид получают следующим образом: 1О г свежеперегнанного анабазина раствор ют в 5О мл ацетона. Раствор после прибавлени 3 х 32 г хлористого аммони нагревают на вод ной бане при температуре кипени растворител цо прекращени выделени аммиака. Аммиак поглощают 1 н. серной кислотой. На спецую- щий день хлоргидрат отсасьшают и промывают сухим ацетоном. Выход 11,9 (97,5%), по количеству выдепившегос аммиака - Anabazine hydrochloride is prepared as follows: 1 O g of freshly distilled anabazine is dissolved in 5 O ml of acetone. After adding 3 x 32 g of ammonium chloride, the solution is heated in a water bath at the boiling point of the solvent to stop the release of ammonia. Ammonia absorb 1 n. sulfuric acid. On the special day, the hydrochloride is sucked off and washed with dry acetone. Output 11.9 (97.5%), by the amount of ammonia exhaled -
выход 92%. После перекристалпйзации из смеси ацетона со спиртом хпоргицраг анабазина имеет т. jin. 194-195 С.yield 92%. After recrystallization from a mixture of acetone with alcohol, Hporgizrag anabazina has t. Jin. 194-195 S.
1ОО г анабазина-основани раствор ют в 2ОО мл. абсолютного изопропипового спирта и при посто нном перемешивании и охлажцении льдом припивают 86 г 30%ного раствора хлористого водорода в абсопютном изопропиповом спирте цо рН 5,56 ( при этом температура реакционной оме си не допжна превыщать 2О-25 С). Выпавщий осадок анабазина гидрохлорида отсасывают , два раза с выкладкой промывают по 15О мл ацетоном и полученный, такимобразом , технический продукт перекристаппизовывают из 4-X объемов абсолютного изо- пропипового спирта.1OO g of anabasine base is dissolved in 2OO ml. absolute isopropyl alcohol and with constant stirring and cooling with ice, nip 86 g of a 30% solution of hydrogen chloride in absintuous isopropyl alcohol of pH 5.56 (while the temperature of the reaction mixture does not exceed 2 O – 25 C). The precipitated anabasine hydrochloride precipitate is sucked off, washed twice with a calculation of 15 O ml with acetone and the technical product obtained in this way is recrystallized from 4-X volumes of absolute isopropyl alcohol.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU1710668A SU530684A1 (en) | 1971-10-27 | 1971-10-27 | Medication for the treatment of chronic nicotinism |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU1710668A SU530684A1 (en) | 1971-10-27 | 1971-10-27 | Medication for the treatment of chronic nicotinism |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU530684A1 true SU530684A1 (en) | 1976-10-05 |
Family
ID=20491843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU1710668A SU530684A1 (en) | 1971-10-27 | 1971-10-27 | Medication for the treatment of chronic nicotinism |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU530684A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0573568A4 (en) * | 1991-03-01 | 1994-09-21 | Univ Florida | Use of nicotinic analogs for treatment of degenerative diseases of the nervous system |
-
1971
- 1971-10-27 SU SU1710668A patent/SU530684A1/en active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0573568A4 (en) * | 1991-03-01 | 1994-09-21 | Univ Florida | Use of nicotinic analogs for treatment of degenerative diseases of the nervous system |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO149312B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2- (2-TENOYLTIO) -PROPIONYLGYLINE | |
| JPS62158251A (en) | Optically pure compound and manufacture | |
| SU530684A1 (en) | Medication for the treatment of chronic nicotinism | |
| JP3253302B2 (en) | Parenteral solution containing 3-dialkylaminoethoxybenzoyl-benzofuran | |
| US3071509A (en) | N-alkyl-nornicotine:nicotine antagonist | |
| Whipple et al. | Blood Regeneration in Severe Anemia: III. Iron Reaction Favorable—Arsenic and Germanium Dioxide Almost Inert | |
| US3928609A (en) | Non-alcoholic theophylline product | |
| US3422086A (en) | Rutin alkyl sulphonates | |
| US3002886A (en) | Betaine salicylates and the method for their preparation | |
| NO169575B (en) | PROCEDURE FOR PREPARING A GALENIC FORM OF SULPIRIDE | |
| US3993755A (en) | Pharmaceutical composition containing the N-methyl-d-glucosamine complex of 4-methyluracil and use thereof | |
| US2995491A (en) | Method of treating cardiac arrhythmia with 1-(2-diethylaminoethyl)-5-ethyl-5-phenylbarbituric acid | |
| US4057620A (en) | Therapeutic composition with marked polydetoxifying properties, especially with regard to tobacco | |
| JPS60139622A (en) | Carcinostatic agent | |
| CN118812478B (en) | Dandelion flavone derivative and preparation method and application thereof | |
| HU204700B (en) | Process for producing aqueous compositions comprising piperidinyl cyclopentylheptenoic acid derivatives | |
| US3156615A (en) | Antacid composition and method of using same | |
| US4959394A (en) | Novel Guanidinium aspartates | |
| CN113197907B (en) | Application of gardenia acetic acid and derivatives thereof in preparing medicine for treating diabetes | |
| US4883821A (en) | Agent for treating hyperuricemia | |
| US4072758A (en) | Compositions and methods for effecting glucoreduction | |
| KR100666606B1 (en) | Clotrimazole-containing rectal suppository composition | |
| RU2181051C1 (en) | Method to obtain injection preparation based upon a substance of p-vitamin activity | |
| JPS6429312A (en) | Antiallergic agent | |
| US3961064A (en) | Pharmaceutical composition for remedy of hyperammoniemia |